Procurement Summary
Country : USA
Summary : 2 Pam Autoinjectors
Deadline : 15 Aug 2022
Other Information
Notice Type : Tender
TOT Ref.No.: 68538121
Document Ref. No. : 75A50122R00022
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
2 PAM Autoinjectors
Active Contract Opportunity
Notice ID : 75A50122R00022
Related Notice : 2PAMAI-BARDA-2022
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Office : BARDA - ASPR / DAAPPO / BARDA DCMA
General Information
Contract Opportunity Type: Solicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Jul 01, 2022 01:16 pm EDT
Original Date Offers Due: Aug 15, 2022 02:00 pm EDT
Inactive Policy: Manual
Original Inactive Date: Aug 16, 2022
Initiative: None
Classification
Original Set Aside:
Product Service Code: AN12 - Health R&D Services; Health care services; Applied Research
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Place of Performance: Washington, DC USA
Description
This acquisition will allow BARDA to invest Project Bioshield funds for late-stage clinical development, regulatory approval for 2-PAM autoinjectors (as a drug/device combination product) to treat organophosphate (OP) poisoning, including nerve agents, in adult and pediatric populations, and procurement of 2-PAM autoinjectors for the SNS/CHEMPACK Program.
Questions are due on July 21, 2022. Proposals are due on August 15, 2022.
Attached to this SAM Notice are the following:
1. Request for Proposals ...
Documents
Tender Notice